Laurie Stelzer
Chief Financial Officer, Halozyme Therapeutics.
Companies
- MBX Biosciences, Inc.Board member Jan 22, 2026 to now1
- Sionna Therapeutics, Inc.Board member Feb 6, 2025 to now2
- Aeglea BioTherapeuticsBoard member Nov 27, 2023 to now3
- PMV Pharmaceuticals, Inc.Board member Sep 24, 2020 to now4
- Mirati Therapeutics, Inc.Chief financial officer May 16, 2022 to Aug 10, 20235
- Surface Oncology, Inc.Board member Apr 18, 2018 to Jun 10, 20226
- Arena PharmaceuticalsChief financial officer Mar 17, 2020 to Mar 11, 20227
- Halozyme TherapeuticsChief financial officer Jun 16, 2015 to Feb 24, 20208
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Arena Pharmaceuticals ARNA0 shares9Mar 11, 2022- Mirati Therapeutics, Inc.102,312 shares10Aug 9, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 9, 2023Granted 22,297 shares at $37.00 of Mirati Therapeutics, Inc.10
- Jun 2, 2023Sold 4,647 shares at $37.06 of Mirati Therapeutics, Inc.11
- Jan 20, 2023Granted 26,864 shares of Mirati Therapeutics, Inc.12
- Jun 1, 2022Granted 57,798 shares of Mirati Therapeutics, Inc.13
- Mar 11, 2022Other 21,462 shares of Arena Pharmaceuticals9
- Mar 11, 2022Other 6,660 shares of Arena Pharmaceuticals9
- Mar 11, 2022Other 9,086 shares of Arena Pharmaceuticals9
- Jan 3, 2022Granted 21,462 shares of Arena Pharmaceuticals14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMBX Biosciences, Inc., Board member
- 2
- 3SEC EDGARAeglea BioTherapeutics, Board member
- 4
- 5
- 6SEC EDGARSurface Oncology, Inc., Board member
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jun 2, 2023
- 12SEC EDGARForm 4 filed Jan 24, 2023
- 13SEC EDGARForm 4 filed Jun 3, 2022
- 14SEC EDGARForm 4 filed Jan 5, 2022